Extended Stability of Reconstituted Lyophilized Erwinia L-asparaginase in Vials

Background/Aim: L-Asparaginase (L-ASNase) is used as a tumor-inhibitory drug on paediatric acute lymphoblastic leukemia (ALL). ERW-ASNase is commercialised as a lyophilized powder stable only for 8 hours once reconstituted and, consequently, the leftover is usually discarded. The aim of this study w...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:In Vivo
Prif Awduron: VIÑA-ROMERO, MICAELA M, RAMOS-DIAZ, RUTH, MOURANI-PADRON, IVETTE, GONZALEZ-MENDEZ, HECTOR, GONZALEZ-CRUZ, MACARENA, NAZCO-CASARIEGO, GLORIA, MERINO-ALONSO, JAVIER JULIA F., DIAZ-VERA, JESICA, GUTIÉRREZ-NICOLÁS, FERNANDO
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International Institute of Anticancer Research 2020
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652457/
https://ncbi.nlm.nih.gov/pubmed/32871767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12055
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg